Hoping to manage your weight, but not on board to take GLP-1 agonists
Personalized Nutrition and Appetite Regulation: Advancements in genomics, metabolomics, and microbiome studies have motivated manufacturers to develop personalized dietary interventions to maximize in vivo GLP-1 secretions
J Athl Train
Typical early side effects include nausea, appetite loss, mild digestive upset, and fatigue while the body adjusts to the dose
While this is the licensed indication, it's important to note that NICE guidance (TA875) recommends more specific criteria for NHS use: typically for people with a BMI 35 kg/m (lower thresholds may apply for some ethnic groups) with at least one weight-related comorbidity, prescribed within specialist weight management services, and limited to a maximum treatment duration of 2 years
In addition, some quinone compounds, such as -LAPachone and aloin, have similar effects on heart protection [182, 183]